Understanding Probiotics and Infant Colic: The BioGaia Advantage

What Are Probiotics?

Probiotics are live microorganisms that, when administered in adequate amounts, provide health benefits to the host. For a probiotic strain to be effective, it must have:

• Proven safety and efficacy
• The ability to colonise the gut
• A well-researched mode of action
• A host-specific origin

One of the Most Studied Probiotics in the World

BioGaia’s probiotic strains have been extensively researched and tested, ensuring their effectiveness and safety:

• 21,000+ individuals studied across all age groups
• 126 clinical trials in children (newborns to 18 years old)
• 131 clinical trials in adults (as of December 2022)

BioGaia’s Probiotic Strains Featuring L. reuteri

BioGaia offers targeted probiotic formulations designed for various aspects of health:

• Protectis – Supports gut comfort (170 published articles); found in BioGaia Baby Drops
• Prodentis – Promotes gum and teeth health (66 published articles)
• Gastrus – Supports gastrointestinal health (8 published articles)
• Osfortis – Aids bone health (1 published article)
• Colus – Supports colon health (2 published articles; product under development)

BioGaia Protectis Baby Drops: Clinically Proven Benefits

BioGaia Protectis Baby Drops are designed to support infant digestive health and alleviate colic symptoms. Clinical studies have shown they:

• Reduce crying time by 56% in colicky infants.
• Increase bowel movements in both constipated and healthy infants.
• Reduce regurgitation episodes.
• Are milk-free, gluten-free, and lactose-free, making them suitable for sensitive babies

Understanding Infant Colic

Infant colic is a functional gastrointestinal disorder that affects gut-brain interaction. Key facts:

• Affects up to 20% of infants.
• One of the most common reasons for paediatric visits.
• Linked to gut microbiome imbalances.
• Defined as 3+ hours of crying per day, for 3 consecutive days in a week.
• Typically emerges between 2-6 weeks and resolves by 4 months

The Most Researched Probiotic for Infant Colic

BioGaia’s patented L. reuteri Protectis (DSM 17938) is the most studied probiotic for infant colic worldwide:

• Randomised, double-blind, placebo-controlled study (80 breastfed colicky infants) showed a significant reduction in crying time after 21 days.
• Prospective, observational study (120 colicky infants) found that maternal depression also improved as babies’ colic symptoms eased.

Preventative Benefits of L. reuteri Protectis

Using L. reuteri Protectis preventatively has been shown to:

• Reduce crying time by 54% after one month.
• Be safe for use from birth

Why Choose BioGaia Protectis Baby Drops?

• Backed by 30 years of clinical research
• Supported by 11 clinical studies proving its effectiveness in reducing colic symptoms
• Safe for use from birth, even without a formal colic diagnosis
• Also available with vitamin D for added immune support—ideal for babies with limited sun exposure

BioGaia: A Global Leader in Probiotics

• A trusted name in clinical research and sales worldwide
• Proven more effective than simethicone for managing infant colic
• Supports overall gut health and immune function

The Takeaway

BioGaia Protectis Baby Drops provide a science-backed, safe, and effective solution for reducing colic symptoms, easing digestive discomfort, and supporting your baby’s gut health. With extensive research and a long-standing reputation, BioGaia remains a top choice for parents looking to nurture their baby’s wellbeing from the very start.

References

1. Benninga M.A. et (2016). Functional Gastrointestinal Disorders in Infancy: Pediatric Aspects.

Gastroenterology, 150(6), 1443-1455

2. Ouald A. et al. (2020). Gut Microbiota and Infant Colic: Mechanisms and Potential Therapeutic Targets.

Frontiers in Pediatrics, 8, 397.

3. Szajewska et al. (2013). Lactobacillus reuteri DSM 17938 for the Management of Infantile Colic: A Randomised, Double-Blind, Placebo-Controlled Trial. The Journal of Pediatrics, 162(2), 257-262.
4. Indrio et al. (2014). Prophylactic Use of a Probiotic in the Prevention of Colic, Regurgitation, and Functional Constipation: A Randomised Clinical Trial. JAMA Pediatrics, 168(3), 228-233.
5. Wadhwa et al. (2022). Maternal Depression and Infant Colic: The Role of Probiotics. European Journal of Pediatrics, 181(5), 1895-1903.